FRANKFURT, Germany, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Arla Foods Ingredients and wheyco, DMK Group's whey business, are to exhibit together at a trade event for the first time since the merger of their parent companies.

On 1st June, Arla Foods and DMK Group came together to form Europe's largest dairy cooperative. At Fi Europe (17th-19th November in Frankfurt), Arla Foods Ingredients, a subsidiary of Arla Foods, will demonstrate how the merger has created a stronger ingredients business.

The DMK Group and Arla Foods Ingredients stands will be located opposite one another, both carrying the message 'Growing Stronger Together', with DMK's subsidiary wheyco represented on the Arla Foods Ingredients stand.

Anne Widart, Vice President, Commercial, at Arla Foods Ingredients said: "One of the many benefits of the merger has been the creation of an ingredients powerhouse. It has unlocked new synergies and opportunities, allowing us to build something even better for the future. Fi Europe is the perfect platform to demonstrate our shared ambitions."

Earlier this year, Arla Foods Ingredients debuted its 'Targeted GLP-1 Companion Nutrition' concept, demonstrating how nutrient-dense products can meet the needs of GLP-1 users. At Fi Europe, it will showcase new applications, including a spoonable yogurt, a drinking yogurt, a fermented high-protein shot and a high-protein water-based shot.

The 'Unlock Permeate' concept will demonstrate how Arla Foods Ingredients' Variolac can improve cost-effectiveness and sensory properties in dairy, bakery and confectionery applications. Produced through nanofiltration, the whey permeate ingredient offers a mild milky taste, high cost efficiency and high content of calcium, magnesium and potassium.

Visitors can also sample new active nutrition solutions, including protein shakes, protein waters and the AirBar - an aerated milk protein bar with a light texture offering a new sensory experience in the protein bar category.

Anne Widart added: "These concepts typify Arla Foods Ingredients' commitment to innovation, from GLP-1 companion nutrition and active nutrition to improving taste and cost efficiency with whey permeate. With our expertise and capabilities further enhanced by the merger, we can deliver even greater value to our customers."

Meanwhile, DMK Industry will showcase its fat-filled ingredients, TOPPICS, FATTICS and BATTICS, and Sweetened Condensed Milk portfolios through four indulgent concepts: cupcakes with an aerated topping, chocolate caramel cookies, chocolate espresso fudge and a Cafe Bomb?n.

Arla Foods Ingredients will exhibit at Stand #30J94, opposite DMK Group at #30K94.

Copyright 2026 GlobeNewswire, Inc.

November 3, 2026

Q3 2026 Group performance

Comparable order intake increased by 8%, driven by strong Diagnosis & Treatment

Group sales of EUR 4.4 billion, reflecting 3% comparable sales growth

Income from operations of EUR 165 million

Adjusted EBITA margin increased 70 basis points to 13.0%, with expansion across all business segments

Operating cash flow of EUR 544 million; free cash flow of EUR 384 million

Respironics reached agreement in principle with the US Department of Justice

Philips reiterates its full-year 2026 outlook

Roy Jakobs, CEO of Royal Philips:

"We delivered an excellent 8% comparable order intake, led by broad-based order momentum in Diagnosis & Treatment, and 3% comparable sales growth in the third quarter, led by Personal Health and Connected Care. Our innovations and productivity measures drove continued margin expansion across all business segments.

We are executing our plan to accelerate profitable growth, with strong customer demand for our latest AI-enabled innovations, including our new CT platforms Verida and Rembra, our latest ultrasound system Alturion, and our HealthSuite Imaging cloud solution. These innovations demonstrate how our platforms bring together hardware, software, data and AI to create greater value for customers. We look forward to showcasing our next innovations at RSNA later this month.

We continue to make progress in resolving the consequences of the Sleep & Respiratory Care recall. The Respironics agreement in principle with the US Department of Justice marks an important step in this process.

Our year-to-date results, together with our strong order book, give us confidence in delivering our full-year outlook and achieving our medium-term ambitions. As we move forward in collaboration with customers, our hardworking teams around the world are focused on putting quality at the heart of our operations as we deliver better care for more people."

Group and segment performance

Comparable order intake grew 8%, driven by strong growth in Diagnosis & Treatment. Comparable sales increased by 3%, driven by Personal Health and Connected Care.

Adjusted EBITA margin increased 70 basis points to 13.0%, mainly driven by higher sales, higher gross margin and productivity measures, partly offset by cost inflation. Net cash flows from operating activities increased to EUR 544 million, mainly driven by higher cash earnings and lower working capital outflows. Free cash flow increased to EUR 384 million.

Diagnosis & Treatment comparable sales growth was flat. Growth in Image Guided Therapy was offset by a decline in Precision Diagnosis, mainly due to phasing of Ultrasound sales and lower sales in China as previously communicated at Q2. Adjusted EBITA margin increased 50 basis points to 12.3%, mainly driven by gross margin from innovation and productivity measures, partly offset by cost inflation.

Connected Care comparable sales increased by 5%, driven by growth in all businesses. Adjusted EBITA margin increased 190 basis points to 13.3%, mainly driven by higher sales, higher gross margin, and productivity measures, partly offset by cost inflation.

Personal Health comparable sales increased by 8%. Adjusted EBITA margin increased 60 basis points to 17.7%, mainly driven by higher sales and productivity measures, partly offset by advertising and promotion spend.

Innovation highlights

Philips is accelerating innovation in image-guided therapy. In the Netherlands, Philips is investing EUR 50 million in AI, robotics and advanced imaging, alongside over EUR 100 million from the Dutch government and a further EUR 150 million in private financing by Invest-NL and institutional investors, including pension funds. In the US, an ARPA-H award of up to USD 34 million will support AI-enabled robotic stroke care on the Azurion platform.

The Philips-coordinated European COMBINE-CT project advanced into clinical validation, launching five clinical studies to evaluate an integrated care pathway enabled by AI-powered CT and Spectral CT imaging solutions.

Philips extended its monitoring partnership with one of the largest US health systems through 2034. The national agreement covers equipment and services, expands the use of Philips' Capsule platform, and supports future technology needs.

Ontario Health in Canada selected the Philips Enterprise Imaging Vendor Neutral Archive to modernize province-wide imaging infrastructure and connect patient information across care settings. This Vendor Neutral Archive will support the sharing of more than 20 million imaging studies annually across more than 150 hospitals and 50 imaging clinics, helping enable a holistic patient view and more timely access to care.

Philips is supporting major healthcare programs in Latin America, including the modernization of 50 public hospitals in Venezuela, and an expanded partnership with Mexico's largest public healthcare institution, IMSS. The projects bring advanced imaging, image-guided therapy and monitoring technologies to more patients, expanding access to diagnostic, cardiac, neurological and stroke care.

Philips signed a long-term strategic partnership with Asia Medical Group to advance integrated cardiovascular care in China. The partnership will focus on clinical care, training, research and international collaboration, combining Philips' diagnostic imaging and image-guided therapy capabilities with Asia Medical Group's cardiovascular expertise.

Personal Health launched innovations across oral care, beauty and mother and child care. These include the AI-powered Sonicare DiamondClean 9900 Prestige, the first at-home IPL with real-time guidance Lumea 9900 Pro, and Philips Avent's first fully wearable Natural Care breast pump, bringing more personalized and premium solutions to consumers.

Productivity

Disciplined cost management and productivity initiatives delivered EUR 170 million in net savings in the quarter and EUR 427 million year-to-date. The company remains on track to deliver EUR 1.5 billion in savings under its 2026-2028 productivity program.

Progress on Respironics-related legal proceedings

Philips Respironics reached an agreement in principle with the US Department of Justice (DOJ) to resolve the previously disclosed criminal and civil investigations related to the Respironics recall. As a result, Philips recorded a provision of EUR 288 million in the third quarter of 2026. The settlement is subject to finalization of the relevant documentation; payment is expected in the first quarter of 2027.

Also in the third quarter, the Enterprise Chamber of the Amsterdam Court of Appeal denied requests from certain investors for an investigation into the affairs of Philips in connection with the Respironics recall.

Outlook

Philips reiterates its full-year 2026 outlook:

Comparable sales growth: 3%-4.5%

Adjusted EBITA margin: 13.5%-14.0%, including a US tariff refund benefit of approximately 1%

Free cash flow: EUR 1.5-1.7 billion, including a net US tariff refund benefit of approximately EUR 200 million

Within the context of an uncertain macro-environment, Philips' 2026 outlook includes currently known tariffs and assumes payment of the US Department of Justice settlement in the first quarter of 2027. The outlook excludes other ongoing Philips Respironics-related proceedings, including the investigation by the US State Attorneys General.

Capital allocation

In the third quarter, Philips issued EUR 650 million fixed rate notes due 2034 (the "Notes") under its European Medium Term Note program. The Notes are the healthcare industry's first EU Green Bond under the new European Green Bond Standard and were 2.7 times oversubscribed, reflecting strong investor demand. An amount equivalent to the gross proceeds will be used to finance taxonomy-aligned economic activities as referred to in the Philips European Green Bond Factsheet, supporting Philips in delivering on its 2030 Impact Ambitions. See here for more information on Philips' current debt structure.

Further information: conference call, video webcast and website

Roy Jakobs, CEO, and Charlotte Hanneman, CFO, will host a conference call for investors and analysts at 10:00 am CET on November 3, 2026, to discuss the results. A live webcast will be available on the Philips Investor Relations webpage and can be accessed here. A replay and related materials, including additional information on the outlook and forward-looking statements, will be available on the Philips Investor Relations webpage.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips' patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in image-guided therapy, diagnostic imaging, ultrasound, monitoring, enterprise informatics and personal health. Philips generated 2025 sales of approximately EUR 18 billion and employs approximately 63,900 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Forward-looking statements and other information

Forward-looking statements

This document and the related oral presentation, including responses to questions following the presentation, contain certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about our strategy, estimates of sales growth, future Adjusted EBITA*, future restructuring and acquisition-related charges and other costs, future developments in Philips' organic business and the completion of acquisitions and divestments. Forward looking statements can be identified generally as those containing words such as "anticipates", "assumes", "believes", "estimates", "expects", "should", "will", "will likely result", "forecast", "outlook", "projects", "may" or similar expressions. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.

These factors include, but are not limited to, macro-economic and geopolitical changes - including the war in Ukraine and ongoing tensions in the Middle East - as well as measures such as enacted and proposed tariffs and trade actions introduced in response to rising global tensions; Philips' ability to keep pace with the changing health technology environment; Philips' ability to gain leadership in artificial intelligence and health informatics in response to developments in the health technology industry; integration of acquisitions and their delivery on business plans and value creation expectations; ability to meet expectations with respect to ESG-related matters; securing and maintaining Philips' intellectual property rights, and unauthorized use of third-party intellectual property rights; failure of products and services to meet quality or security standards, adversely affecting patient safety and customer operations; the resilience of our supply chain; challenges in simplifying our organization and our ways of working; attracting and retaining personnel; breach of cybersecurity; challenges in driving operational excellence and speed in bringing innovations to market; treasury and financing risks; tax risks; reliability of internal controls; compliance with regulations and standards involving quality, product safety, (cyber) security and artificial intelligence; and compliance with business conduct rules and regulations including privacy, existing and upcoming ESG disclosure and due diligence requirements. As a result, Philips' actual future results may differ materially from the plans, goals and expectations set forth in such forward-looking statements. For a discussion of factors that could cause future results to differ from such forward-looking statements, see also the Further information chapter included in the Annual Report 2025.

Third-party market share data

Statements regarding market share contained in this document, including those regarding Philips' competitive position, are based on outside sources such as specialized research institutes, as well as industry and dealer panels, in combination with management estimates. Where information is not yet available to Philips, market share statements may also be based on estimates and projections prepared by management and/or based on outside sources of information. Management's estimates of rankings are based on order intake or sales, depending on the business.

Market Abuse Regulation

This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

Use of non-IFRS information

In presenting and discussing the Philips Group's financial position, operating results and cash flows, management uses certain non-IFRS financial measures. These non-IFRS financial measures should not be viewed in isolation as alternatives to the equivalent IFRS measure and should be used in conjunction with the most directly comparable IFRS measures. Non-IFRS financial measures do not have standardized meaning under IFRS and therefore may not be comparable to similar measures presented by other issuers. A reconciliation of these non-IFRS measures to the most directly comparable IFRS measures is contained in this document. Further information on non-IFRS measures can be found in the Annual Report 2025.

Presentation

All amounts are in millions of euros unless otherwise stated. Due to rounding, amounts may not add up precisely to totals provided. All reported data is unaudited. Financial reporting is in accordance with the accounting policies as stated in the Annual Report 2025. Certain prior year balances have been reclassified to conform to the current period presentation.

Copyright 2026 GlobeNewswire, Inc.

LONDON/HOUSTON/SINGAPORE, Nov. 03, 2026 (GLOBE NEWSWIRE) --  

FOR IMMEDIATE RELEASE

Wood Mackenzie | www.woodmac.com

The Middle East conflict has tested ADNOC, Saudi Aramco and QatarEnergy, while highlighting sharp differences in export flexibility and portfolio diversification. Although all three companies remain resilient, the conflict has increased competing demands on capital, expertise and management attention, strengthening the role of partnerships at home and abroad.

Bypass routes, ship-to-ship shuttle transfers and a partial reopening of the Strait of Hormuz have allowed Aramco and ADNOC to increase combined operating cash flow by around $35 billion, or 25%, against pre-war estimates.

But the recovery remains fragile and bypasses carry their own risks, as Houthi attacks on the East-West pipeline and Red Sea shipping have shown. Flows through the Strait are only partly restored and the windfall depends on elevated prices. QatarEnergy has taken the biggest hit, just as the North Field expansion was due to lift liquefaction capacity from 77 to 142 mmtpa.

In the near term, all three NOCs are focused on restoring capacity and strengthening export resilience. Over the longer term, the conflict will reshape business development priorities - domestic resource access, partnerships and M&A - both at home and abroad.

"The conflict has increased the number of competing priorities facing Middle East NOCs," said Neivan Boroujerdi, Director, Corporate Research, Wood Mackenzie. "ADNOC, Aramco and QatarEnergy all face different challenges, but each is balancing domestic expansion, international growth and resilience simultaneously. Capital is not the constraint. Access to technology, markets and operational capability will shape the next phase, strengthening the role of partnerships across the sector."

Key findings:

ADNOC is leading the recovery. Freed from OPEC quotas, it is looking beyond its 5 million b/d target for 2027, with 6 million b/d mooted for the early 2030s. Hopes rest on unconventionals and additional phases at existing concessions. Its global LNG platform, formed in July 2026, targets 47 mmtpa of marketable LNG by 2035, which would rank it in the top five globally on LNG capacity. Delivering oil growth, gas self-sufficiency and international expansion simultaneously is likely to increase reliance on strategic partners and technical expertise.

Saudi Aramco's domestic gas expansion, and potential LNG exports, may open part of its upstream sector to external participation for the first time. As unconventional gas ramps up, projected sales gas supply of around 180 bcm/y in the early 2030s would outpace domestic demand of around 130 bcm/y, a surplus that could support significant LNG exports. A standalone gas entity could ring-fence gas investment from the oil business and provide a new funding vehicle for domestic gas growth and international LNG opportunities. Equity in that entity could be offered to IOCs or NOCs facilitating LNG swaps, offtake agreements and other commercial arrangements.

QatarEnergy faces the greatest strategic challenge due to long-term facility damage, lost production and continued dependence on the Strait. Repair costs could trigger IOC contract extensions, with ExxonMobil among the most exposed. The outcome for IOCs remains uncertain, potentially increasing near-term costs while extending participation. Exploration remains central to QatarEnergy's international strategy, but it should also consider development-stage acquisitions that can accelerate production growth and build technical capability.

Background:

Interest among IOCs and international NOCs in Middle East resources will remain high. Uncertain and volatile environments make low-cost barrels attractive, and the Middle East has the lowest of the lot. The region already accounts for around 15% of the Majors' production today, rising to 17% by 2030. However, elevated geopolitical risk may lead some international companies to become more selective about future exposure and NOCs may need to widen their partnership pool to new entrants.

The conflict has reinforced the strategic rationale for international diversification in gas (ADNOC and Aramco) and exploration (QatarEnergy). But competition for non-Hormuz LNG and US gas will intensify, building on pre-war deals struck largely at or above Wood Mackenzie's  base-case NPV10. Ultimately, internationalisation is becoming less about growth and more about resilience through diversification. As NOCs balance domestic expansion with international growth ambitions, collaboration with IOCs will be required across upstream, gas and LNG development.

You have received this news release from Wood Mackenzie because of the details we hold about you. If the information we have is incorrect you can either provide your updated preferences by contacting our media relations team. If you do not wish to receive this type of email in the future, please reply with 'unsubscribe' in the subject header.  

About Wood Mackenzie:

Wood Mackenzie is the global leader in analytics, insights and proprietary data across the entire energy and natural resources landscape. For over 50 years our work has guided the decisions of the world's most influential energy producers, utilities companies, financial institutions and governments. Now, with the world's energy system more complex and interconnected than ever before, sector-specific views are no longer enough.

That's why we've redefined what's possible with Intelligence Connected: the fusion of our unparalleled proprietary data with the sharpest analytical minds, all supercharged by Synoptic AI, to deliver a clear, interconnected view of the entire value chain. Our trusted team of 2,700 experts across 30 countries breaks siloes and connects industries, markets and regions across the globe to empower our customers to identify risk sooner, spot opportunity faster and make every decision with complete confidence.

Copyright 2026 GlobeNewswire, Inc.

Photo: Siam Piwat the prestigious Alipay+ Growth Award, making it the sole recipient from Thailand, and one of the only two countries in Asia recognized at Ant International's VOYAGE 2026 & Gala Dinner in Shanghai, China.

Expanding its global partnership ecosystem through strategic collaborations with Huawei and iQIYI enables Siam Piwat to seamlessly integrate technology, entertainment, and luxury, delivering an end-to-end tourism experience for high-value Chinese tourists.

BANGKOK, THAILAND - Media OutReach Newswire - 3 November 2026 - Siam Piwat Group, a leading developer and operator of world-class landmarks, including Siam Paragon, Siam Center, Siam Discovery, ICONSIAM, and Siam Premium Outlets Bangkok, has announced the remarkable success of its global partnership ecosystem strategy.

Through its collaboration with premier partners to expand its high-value tourist base and stimulate spending, Siam Piwat saw its Golden Week sales double year-on-year. Furthermore, the strong performance earned Siam Piwat the prestigious Alipay+ Growth Award, making it the sole recipient from Thailand, and one of the only two countries in Asia recognized at Ant International's VOYAGE 2026 & Gala Dinner in Shanghai, China.

Alipay+ is the unified wallet gateway of Ant International, connecting global wallets like Alipay (China) and other leading payment apps across Siam Piwat retail touchpoints, while offering direct user engagement and exclusive campaigns in-app.

This milestone is the outcome of partnerships with leading payment service providers, including Alipay+, WeChat Pay, and UnionPay, to curate targeted campaigns and exclusive privileges for Chinese travelers, particularly high-value visitors and enthusiasts of luxury products.

Building on this success, Siam Piwat has expanded its collaboration with global tech leader Huawei and China's leading entertainment platform iQIYI to bridge the platforms' user bases with travel and retail experiences in Thailand, engaging visitors throughout the entire customer journey, from pre-trip inspiration to on-site spending and activities at the destination.

Another distinctive highlight is Siam Piwat's collaboration with Trip.com, which connects travel offers on Ctrip's WeChat Mini Program with exclusive privileges at MINISO ICONSIAM. This allows Chinese tourists to enjoy special benefits even before they arrive in Thailand. This model enables us to engage Chinese travelers during the trip-planning stage, introducing them to Siam Piwat's shopping destinations and the privileges available through the ONESIAM Global Visitor Card.

Chinese Partnerships Drive Transaction Growth

Since 2018, Siam Piwat has collaborated with Alipay+ to develop and deliver marketing campaigns, exclusive privileges, and digital payment solutions for international visitors. In the first eight months of 2026, transactions via Alipay+ grew 2.3-fold, while the number of active users surged 2.5 times compared to the same period last year.

During the Golden Week holiday, Siam Piwat partnered with Alipay+ and WeChat Pay to launch exclusive campaigns and tailored promotions for Chinese visitors across retail shops and luxury brands. This initiative drove a 100% year-on-year surge in sales, demonstrating the effectiveness of partnerships in boosting tourist spending.

As a result of these achievements, Siam Piwat was honored with the Alipay+ Growth Award as the sole winner from Thailand, one of the only two countries in Asia recognized at the VOYAGE 2026 & Gala Dinner in Shanghai, underscoring its success in driving digital transaction growth alongside its partners.

Partnership with Huawei for Pre-Arrival Engagement

Siam Piwat has expanded its tech alliance with Huawei to access Chinese consumers across their smartphone and wearable devices. This integration connects users directly to the ONESIAM Global Visitor Card, a digital membership card through which travelers can register, discover information, plan shopping itineraries, and unlock privileges from premier brands even before departing for Thailand.

Furthermore, travelers can sign up via a one-click WeChat Mini Program, minimizing repetitive form-filling and offering greater convenience. International visitors from other countries can also register via the official website or Huawei Wearables.

This initiative forms part of Siam Piwat's pre-arrival engagement strategy, designed to build brand awareness and inspire travelers right in the home country before their actual experiences at Siam Piwat's five landmarks. The program also offers year-round "always-on" privileges, ranging from best deals and luxury retail campaigns to exclusive offers, extending benefits beyond peak travel seasons.

Joining Forces with iQIYI to Attract Chinese Fans Through Fandom Marketing

Siam Piwat has also joined forces with iQIYI, China's leading streaming platform with premium Asian content, to spearhead a fandom marketing strategy under the concept of "From Screen to Real-World Experience," capitalizing on the popularity of Chinese artists and entertainment content to generate motivation for a trip to Thailand.

Among the pilot activities was the iQIYI Starship: Spring of The Blade Meet & Greet, which brought Chinese superstar Xu Kai to meet fans at Siam Paragon. The event generated massive social media buzz and expanded brand visibility across fan communities in mainland China and around the world. By connecting iQIYI's fan base to real-world experiences at Siam Paragon, the partnership has enhanced destination recall and inspired travel, particularly among younger generations of tourists.

Expanding the Global Ecosystem to Unlock New Growth Opportunities

Siam Piwat has been working actively to expand its global ecosystem through alliances with leading international partners across technology, tourism, payment solutions, and entertainment, including Huawei, iQIYI, Trip.com, Alipay+, WeChat Pay, and UnionPay, with the ultimate goal of connecting travelers to its ecosystem throughout every phase of their journey, from pre-trip planning to dining, lifestyle activities, and shopping in Thailand.

Furthermore, Siam Piwat is enhancing campaigns and exclusive privileges for high-spending travelers, especially in the luxury segment, to maximize spending potential and reinforce Siam Paragon and ICONSIAM's positions as premier luxury shopping destinations in the region.

This strategy reinforces Siam Piwat's position as a global destination and ecosystem developer and a partner of choice for leading global enterprises. By transforming partnership networks into concrete business results, Siam Piwat continues to attract high-quality tourists, increase spending value, and create growth opportunities for Thailand's tourism economy.

For more information and exclusive privileges via the ONESIAM Global Visitor Card, please visit:

Website: https://tourist.onesiam.com/en/tourist-card-privileges/

Instagram: https://www.instagram.com/onesiamglobal/

Siam Piwat

Siam Piwat is a leading retail and real estate developer behind Bangkok's most iconic destinations, including Siam Paragon, Siam Center, Siam Discovery, ICONSIAM, and Siam Premium Outlets Bangkok, globally recognized for pioneering experiential destinations.

For over six decades, Siam Piwat has been renowned for creating iconic destinations and world-class experiences, continuously redefining Bangkok's retail landscape through award-winning developments that set new global benchmarks. Guided by creativity, innovation, and sustainability, the company continues to lead with a bold vision that inspire, engage, and delight customers from around the world, while creating long-term value for society, businesses, and future generations.

The issuer is solely responsible for the content of this announcement.

Hashtags: #SiamPiwat #ONESIAMGlobalVisitorCard #ONESIAMGlobal #GlobalPartnershipEcosystem #GlobalDestination #TourismEconomy

https://www.siampiwat.com/en/home

https://www.linkedin.com/company/siam-piwat/

https://www.facebook.com/siampiwat.official/

https://www.instagram.com/siampiwat_official/

SG-INSIGHT study will extend whole- genome sequencing to nearly 1 in 10 Singapore residents, generating evidence to inform how precision medicine could be implemented in Singapore's healthcare system

SINGAPORE - Media OutReach Newswire - 3 November 2026 - Illumina, Inc. (Nasdaq: ILMN) today announced it has been selected to provide whole-genome sequencing services for the SG-INSIGHT study, a cohort under Phase III of Singapore's National Precision Medicine (NPM) programme.

Expected to include approximately one in 10 Singapore residents, or around 450,000 individuals, the study is designed to generate evidence from genomic and health data to help inform preventive approaches to healthcare.

The study marks an important and planned transition from studying genomics primarily in healthy volunteers to studying those with a broad range of medical conditions. By connecting genomic information with real-world health data, SG-INSIGHT aims to better understand disease and treatment responses, support the responsible introduction of genetic screening in Singapore's public healthcare system, and help healthcare become more tailored to individuals over time.

"Singapore is showing what the future of precision medicine can look like at national scale," said Jacob Thaysen, Chief Executive Officer of Illumina. "By bringing genomic information closer to everyday healthcare, this programme has the potential to advance understanding of disease, generate evidence that support more informed care decisions, and ultimately move healthcare toward earlier, more precise intervention. We are proud to bring Illumina's technology, expertise and longstanding presence in Singapore to help make that vision possible."

"Phase III builds on nearly a decade of precision medicine in Singapore," said Professor Patrick Tan, Executive Director of PRECISE. "By extending the programme to patients across the public healthcare system, SG-INSIGHT aims to deepen understanding of how genetic, lifestyle and environmental factors are associated with health and disease. Phase III reflects Singapore's ambition to build a trusted and sustainable precision health ecosystem grounded in the needs and diversity of its population."

Illumina will perform the sequencing in Singapore through its local genomics facility where scientific, laboratory and bioinformatics teams will oversee sample preparation, sequencing, and genomic data analysis. Co-located with Illumina's manufacturing and R&D operations, the facility will seek the necessary accreditation and comply with Singapore's Healthcare Services Act 2020 (HCSA), strengthening its commitment to quality, safety, regulatory compliance and biomedical innovation.

Illumina's selection for the SG-INSIGHT Study was awarded through an international competitive tender. It builds on an existing multi-year engagement, through which Illumina supported the successful implementation and delivery of NPM Phase II, PRECISE-SG100K, covering more than 100,000 genomes from healthy volunteers.

"For nearly two decades, Singapore has been one of Illumina's most important centres for innovation, manufacturing and talent in Asia Pacific," said Nilesh Shah, Head of Region, Asia Pacific, Illumina. "Our long-standing relationship with PRECISE represents the next chapter in that commitment - combining Singapore's leadership in precision health with Illumina's local genomic capabilities and regional expertise. We remain committed to investing in the people, technology and partnerships that can help advance genomics responsibly in Singapore and across the region."

Illumina established its presence in Singapore in 2008. Today, Singapore serves as the company's Asia Pacific regional headquarters and one of its largest hubs outside the United States, with more than 1,700 employees across three locations. Illumina operations in Singapore encompass commercial operations, manufacturing, and R&D, supporting global research and innovation across sequencing platforms, software, and emerging technologies.

About PRECISE

Precision Health Research, Singapore (PRECISE) is the national central entity coordinating Singapore's multi-phase National Precision Medicine (NPM) programme. Established to drive a whole-of-Singapore effort, PRECISE works with research, clinical and industry partners to generate insights into Asian genomics and translate these into better health outcomes and economic opportunities.

PRECISE is a programme of the Consortium for Clinical Research and Innovation, Singapore. NPM Phase II is supported by the National Research Foundation, Singapore (NRF) under the White Space funding (MOH-000588 and MOH-001264) and administered by the Singapore Ministry of Health (MOH) through the National Medical Research Council (NMRC) Office, MOH Holdings Pte Ltd. NPM Phase III is supported by the Singapore MOH through the NMRC Office, MOH Holdings Pte Ltd under the NMRC NPM Phase III Funding Initiative (MOH-001734).

www.npm.sg

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit illumina.com and connect with us on X, Facebook, LinkedIn, Instagram, TikTok, and YouTube.

The issuer is solely responsible for the content of this announcement.

Hashtags: #Illumina #PRECISE

Awarded governments will make vision screening, specialist referral and reading glasses part of the health services people already use

Antigua and Barbuda, Nov. 02, 2026 (GLOBE NEWSWIRE) -- More than 2 billion people globally live with vision impairment. For 1 billion of them, their sight loss is entirely preventable or treatable, but basic eye care is often unaffordable or inaccessible.

Announced today, Vision Action Fund is committing a minimum of $10 million in multi-year catalytic funding to 24 governments to integrate near-vision services and basic eye care into their healthcare systems and expand access to eyeglasses. The Global Vision Impact Awards were presented at the Global Summit for Eye Health by Vision Action Fund and Vital Strategies. 

"Integrating basic eye health services into community health and primary healthcare ensures people get the continuity of care they need throughout their lives," said Abigail Steinberg, Executive Director, Vision Action Fund. "Our gratitude to the Government of Antigua and Barbuda, The International Agency for the Prevention of Blindness (IAPB), and World Health Organization for hosting the first-ever Global Summit for Eye Health and for your foundational and unwavering dedication to bring eye health to everyone, everywhere."  

The awarded governments include Bangladesh, Cambodia, Cameroon, Chad, Ethiopia, Ghana, Madhya Pradesh (India), Indonesia, Kenya, Malaysia, Mauritania, Mexico, Mozambique, Nepal, Nigeria, Peru, Rwanda, Somalia, South Africa, Sri Lanka, Sudan, Uganda, Vietnam, and Zambia. 

"I am encouraged by the commitment governments are making to improving access to essential eye care, and what this will mean for millions of people whose livelihoods and quality of life depend on clear vision," said Dr. Mary-Ann Etiebet, President and CEO, Vital Strategies. "By integrating basic eye care into primary health care, including routine screening for conditions such as diabetes and hypertension, governments can reach more people, identify vision problems earlier, and expand access to affordable solutions. We are proud to work alongside Vision Action Fund in partnership with governments to strengthen the policies and systems needed to make these commitments a sustainable reality." 

Costing less than US$1 to make, reading glasses can increase personal income up to 33%, but policy and regulatory barriers deny access to hundreds of millions. The Global Vision Impact Awards operate in two phases. In the first, governments enact policies that expand access to primary eye care, such as: authorizing over-the-counter sales of reading glasses; expanding the network of primary and community health workers who can screen, refer, and dispense reading glasses; and eliminating tariffs and taxes on glasses.

In the second phase, countries scale up implementation nationally. The Vision Action Fund and partners will provide additional support and a supply of reading glasses for people living with age-related near-vision loss, or presbyopia. Once these strategies scale, governments could reach more than 100 million people and unlock tens of billions in economic productivity.

"For millions of Nigerians, including an estimated 25 million with presbyopia, eye screening and reading glasses will soon be within reach at their local point of care," said the Honourable Minister of State for Health and Social Welfare, Dr. Iziaq Adekunle Salako. "Nigeria's Presidential Initiative has already provided reading glasses to more than 1 million people through primary healthcare channels, and we commit to expanding our reach to 3 million more people over the next 3 years. We are grateful for The Global Vision Impact Award, which recognizes this momentum and partners with us to expand even further, bringing screening, referral, and reading glasses to the last mile. With this initiative, we are demonstrating to the world an effective model for delivering primary eye care at scale."

"We must make eye health part of everyday health care, everywhere," said Peter Holland, CEO, International Agency for the Prevention of Blindness. "That's why we are proud to convene the first-ever Global Summit for Eye Health to transform the way the world sees the value of vision. We commend the governments who have made the social, economic and health commitments to build a world where millions of people have access to quality eye care. Together, they demonstrate growing recognition that investing in eye health is an investment in human potential, economic growth, and sustainable development."

Vision Action Fund partners with Vital Strategies and national and local governments in the awarded countries to integrate eye care into community-level services, streamline retail access to reading glasses, and align policies with the WHO's SPECS 2030 targets, which call for a 40 percentage-point increase in effective refractive error coverage by 2030.

 

About Vision Action Fund 

Vision Action Fund is working to expand access to basic eye care and make reading glasses a routine, self-sustaining part of life across low- and middle-income countries. Incubated by the Livelihood Impact Fund, we partner with governments, health systems, community-based networks, and private markets to unlock investment, drive systems change, and help restore tens of millions of adults' livelihoods, income, and independence. Visit www.visionactionfund.org and follow us on LinkedIn.

About Vital Strategies 

Vital Strategies is a global health organization that believes every person should be protected by an equitable and effective public health system. We work with governments, communities and organizations around the world to reimagine public health so that health is supported in all the places we live, work and play. The result is millions of people living longer, healthier lives.  

To find out more, please visit www.vitalstrategies.org or follow us on LinkedIn.

Copyright 2026 GlobeNewswire, Inc.

Acquisition expands AI Data Center revenue opportunity 

News Highlights:

*Establishes onsemi as a leader in integrated voltage regulator (IVR) technology with best-in-class power density required for next-generation AI processors

*Combines Ferric's engineering talent with expertise in magnetics and power conversion with onsemi's productization capabilities, operating scale and customer relationships

*Raises onsemi's 2030 AI data center revenue target by $500 million to greater than $3 billion, with acceleration thereafter

*Expected to be accretive to onsemi's long-term revenue growth, gross margin, and EPS targets at scale

SCOTTSDALE, Ariz., Nov. 02, 2026 (GLOBE NEWSWIRE) -- onsemi (Nasdaq: ON) today announced that it has entered into an agreement to acquire Ferric, Inc., an innovator in integrated voltage regulator (IVR) technology, for $600 million in cash, plus up to $175 million in contingent consideration upon achievement of certain revenue milestones.

The acquisition will strengthen onsemi's leadership in power delivery to AI processors by adding differentiated power density, efficiency and transient response capabilities, further enhancing the company's portfolio from grid to core. As a result, onsemi is raising its 2030 AI data center revenue target by $500 million to greater than $3 billion, and expects multi-year accelerated growth in its IVR business thereafter.

"The rapid growth of AI is reshaping the requirements for power delivery to increasingly capable and power-intensive processors," said Hassane El-Khoury, President and CEO of onsemi. "Combined with onsemi's broad power portfolio, this strategic acquisition will strengthen our leadership position while expanding our content opportunity and ability to support customers as AI processor architectures continue to evolve."

"Ferric was founded to rethink how power is delivered at the point of compute," said Noah Sturcken, Founder and Chief Executive Officer of Ferric. "We believe integrated power architectures will play an increasingly important role in the future of AI data centers. Joining onsemi gives us the scale, manufacturing capabilities and customer reach needed to accelerate adoption and bring these technologies into the mainstream."

AI Power Demands Accelerate the Transition to IVR

As processor power continues to scale, the industry is moving voltage regulation progressively closer to the processor to reduce losses, increase power density and respond faster to rapidly changing power demands. IVRs represent the next step in this evolution by integrating power conversion directly into the processor package or substrate.

Ferric is at the forefront of this transition with highly differentiated IVR technology that integrates the power controller, FETs, inductors and capacitors into a single compact package. This architecture reduces board area by 50-70% compared with conventional discrete voltage regulator solutions while delivering more power closer to the processor. As a result, customers can dedicate a greater share of system power to AI compute, improving tokens per watt for increasingly power-intensive processors. By adding these capabilities, onsemi is positioned for leadership in AI processor power delivery architectures.

Ferric brings more than a decade of specialized engineering expertise in integrated voltage regulation and advanced magnetics, backed by a portfolio of more than 40 patents. By combining Ferric's differentiated technology with onsemi's productization capabilities, operating scale and broad customer relationships, the acquisition will establish onsemi as a leader in power delivery to next-generation AI processors and advance the commercialization of these technologies at scale.

Transaction Details

Under the terms of the agreement, onsemi will acquire Ferric for $600 million in cash at closing, plus up to $175 million in additional cash consideration tied to the achievement of revenue milestones. The transaction will be funded with cash on hand. Approximately 50 Ferric employees, primarily located in New York and Silicon Valley, are expected to join onsemi. The transaction is expected to close by the end of 2026, subject to customary closing conditions, and is expected to be accretive to onsemi's long-term revenue growth and gross-margin targets at scale. onsemi expects no meaningful near-term financial impact from this transaction.

More Information

Advisors

Barclays served as exclusive financial advisor to onsemi. Morrison & Foerster LLP served as legal counsel to onsemi. UBS Investment Bank served as exclusive financial advisor and Cooley LLP served as legal counsel to Ferric, Inc.

About onsemi

onsemi (Nasdaq: ON) delivers intelligent power and sensing technologies that enable electrification, energy efficiency, safety, and automation across automotive, industrial, and AI data center end‑markets. With a highly differentiated and innovative product portfolio, onsemi helps customers solve complex challenges to achieve higher efficiency, improved performance, and lower system cost, while supporting a safer, cleaner, and more energy‑efficient world. The company is part of the S&P 500? index. Learn more at www.onsemi.com.

About Ferric

Ferric is a leading innovator in Integrated Voltage Regulator (IVR) solutions, specializing in advanced power conversion technologies designed to optimize power delivery in next-generation computing systems. By providing dynamic control over power at the core level, Ferric enables greater computational density, higher efficiency and smarter performance across a wide range of industries. With proven reliability and system-level impact, Ferric's solutions play a pivotal role in unlocking the potential of tomorrow's most demanding technologies.

onsemi and the onsemi logo are trademarks of Semiconductor Components Industries, LLC. All other brand and product names appearing in this document are registered trademarks or trademarks of their respective holders.

Caution Regarding Forward-Looking Statements:

This press release includes "forward-looking statements," as that term is defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.

All statements, other than statements of historical facts, included or incorporated in this press release could be deemed forward-looking statements, particularly statements about the consummation and anticipated benefits of the proposed acquisition of Ferric, including but not limited to: forecasts about the pace, scale and direction of technological change and its impact on onsemi's total addressable market opportunity; statements about onsemi's ability to capitalize on such an opportunity; and the potential impact of each of the foregoing on onsemi's operating results and financial condition.

Forward-looking statements are often characterized by the use of words such as "believes," "estimates," "expects," "projects," "may," "will," "intends," "plans," "anticipates," "should" or similar expressions or by discussions of strategy, plans or intentions. All forward-looking statements in this document are made based on onsemi's current expectations, forecasts, estimates and assumptions and involve risks, uncertainties and other factors that could cause results or events to differ materially from those expressed in the forward-looking statements.

Certain factors that could affect our future results or events are described under Part I, Item 1A "Risk Factors" in the 2025 Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on February 9, 2026 (the "2025 Form 10-K") and from time to time in onsemi's other SEC reports. Readers are cautioned not to place undue reliance on forward-looking statements. onsemi assumes no obligation to update such information, which speaks only as of the date made, except as may be required by law.

Investing in onsemi's securities involves a high degree of risk and uncertainty, and you should carefully consider the trends, risks and uncertainties described in this document, onsemi's 2025 Form 10-K and other reports filed with or furnished to the SEC before making any investment decision with respect to onsemi's securities. If any of these trends, risks or uncertainties actually occurs or continues, onsemi's business, financial condition or operating results could be materially adversely affected, the trading prices of onsemi's securities could decline, and you could lose all or part of your investment. All forward-looking statements attributable to onsemi or persons acting on onsemi's behalf are expressly qualified in their entirety by this cautionary statement.

Copyright 2026 GlobeNewswire, Inc.

The latest partnership introduces limited-edition designs and curated experiences this festive season, bringing a new spirit of celebration to the region

HONG KONG SAR - Media OutReach Newswire - 2 November 2026 - Carlsberg Asia today announced the next chapter of 1664'spartnership with CLOT, launching the festive campaign "Make Celebrations Extraordinary" across the Chinese Mainland, Singapore, Malaysia and Vietnam from November 2026 through February 2027.

Building on the partnership's successful debut Hong Kong last year, 1664, the world's No. 1* French beer brand, and CLOT, the pioneering fashion label founded by Edison Chen, are expanding the East-Meets-French story to a wider audience. The partnership introduces limited-edition 1664 x CLOT beer cans and exclusive merchandise, alongside a series of curated experiences that bring Asia a new way to celebrate across cultures and occasions.

Arindam Varanasi, Commercial Vice President, Carlsberg Asia, said: "The success of our first collaboration with CLOT proved that when 1664 shows up in culture, consumers respond. This year, we are expanding the partnership into the Chinese Mainland which is our largest market - a further step in strengthening our premium portfolio in Asia. By fusing CLOT's dynamic energy with 1664's French heritage, we are bringing our 'unquestionably good taste' spirit to life and redefining celebration across the region."

Make Celebrations Extraordinary: From Design to Moments

At the heart of the campaign is CLOT's signature Silk Royale pattern, a motif inspired by the elegance of Chinese silk, its intricate geometric lines referencing luxurious jacquard with a modern edge. For this collaboration, the pattern is reimagined in vibrant festive hues, flowing across 1664's iconic blue-and-white design in a visual dialogue between Asian tradition and French audacity.

Anchored by 1664's signature cocarde, a nod to the brand's French heritage and brewing craftsmanship, the 1664 x CLOT design motifs commemorate this special time of year. Exclusively for this collaboration, the CLOT's iconic Silk Royale pattern is reimagined in a vibrant, multi-coloured treatment. Illuminated by neon-inspired outlines, the design evokes the glow and vibrant energy of Asia in blues, reds and yellows accented by firework patterns, capturing the uplifting moment when celebrations come alive with 1664.

The interplay between CLOT's richly coloured patterns and 1664's clean red, white and blue palette creates a contemporary elegance that captures the spirit of celebration in style, where East meets French and tradition meets modernity.

Beyond the beer cans, the 1664 x CLOT design motifs extend to a range of exclusive merchandise. The key highlight is a bespoke apparel collection curated by CLOT for the campaign, including T-shirts, socks and caps, each piece infused with festive vibrancy and the collaboration's East-meets-French spirit, bringing the partnership to life beyond the taste and into the moments people share.

The 1664 x CLOT limited-edition products are available from November 2026 through February 2027 in selected supermarkets, bars, restaurants and online across Chinese Mainland, Singapore, Malaysia and Vietnam. A series of on-the-ground activations and market-exclusive premiums will also be rolled out throughout the season, inviting consumers to immerse themselves in festive experiences that make their celebrations extraordinary. For more information, please visit https://www.1664blanc.com/.

*GlobalData 2025 research for 2023, based on actual volume sales data in The Hectolitres.

About Carlsberg

Established in 1847 by brewer J.C. Jacobsen, the Carlsberg Group is one of the leading brewery groups in the world, with an attractive portfolio of beer and other beverage brands. With over 37.000 employees, and with a presence in more than 150 markets, the Group has a purpose of brewing for a better today and tomorrow. Doing business responsibly and sustainably supports that purpose - and drives the efforts to deliver value for shareholders and society.

Carlsberg Asia is a dynamic and diverse region comprising of 8 operating markets: Cambodia, China, Hong Kong S.A.R. (Macau and Taiwan), Laos, Malaysia, Myanmar, Singapore and Vietnam. Altogether we have 35 breweries in operation and some 13,000 employees spreading across the Asian markets. The Asia Regional Office is based in Hong Kong.

About 1664

1664, the world's No.1 French beer brand with a rich heritage spanning over 350 years, epitomizes timeless yet playful elegance. Our brew is distinguished by its lively and refreshing taste profile, with signature citrus notes that deliver impeccable taste in every sip. Inspired by art, design and the French appreciation of life, 1664 elevates everyday moments, turning the ordinary into the extraordinary.​

About CLOT

First established in 2003, CLOT is a pioneering streetwear label and the brainchild of Edison Chen. Conceived from the desire to bridge East and West through thoughtfully-designed apparel and goods, the brand takes its Chinese roots to a worldwide stage, modernizing, reinterpreting, and splices motifs from traditional Chinese culture with bold graphics, exaggerated silhouettes, and a dynamic energy reflective of the new youth of Asia. CLOT has since partnered with the likes of adidas, Bang & Olufsen, Coca-Cola, fragment design, Medicom Toy, Nike, Rimowa, Supreme, St?ssy, sacai and visvim to create sold-out collaborations, solidifying its international presence in the process.

CLOT's vision for a borderless culture of streetwear is further manifested in JUICE, a fashion and lifestyle retailer that expresses an all-encompassing aesthetic through its curation of apparel, home goods, and more. Located in major cities around the world, JUICE can be found in Hong Kong, Shanghai, Taipei, Taichung, and online.

The issuer is solely responsible for the content of this announcement.

Hashtags: #CarlsbergAsia

SOUTHAMPTON, Pa., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Environmental Tectonics Corporation (OTCID: ETCC) ("ETC" or the "Company") was named to TIME's annual list of America's Growth Leaders 2027, ranking 201 among the top 500 companies. This recognition distinguishes ETC for its outstanding growth, performance, and business momentum. 

TIME and market research firm Statista, determined America's Growth Leaders through an analysis of publicly traded companies headquartered in the U.S. Each company was evaluated based on revenue growth, stock performance, and financial stability.

ETC was also recognized in the Philadelphia Business Journal's 2026 FAST 50 list, which highlights the fastest-growing companies in the Greater Philadelphia region. This is the second consecutive year that the Company has been recognized, ranking seventh both years.

Robert Laurent, ETC's President and CEO stated, "Being named one of TIME's America's Growth Leaders is an indicator of the success of the strategic efforts of our entire team, in each of our business units. We are equally honored to be recognized as one of the fastest growing companies in the Greater Philadelphia region for the second year in a row."

About ETC

ETC designs, manufactures, and sells software-driven products and services used to recreate and monitor the physiological effects of motion on humans, and equipment to control, modify, simulate and measure environmental conditions. Our products include aircrew training systems (aeromedical, tactical combat, and general), disaster management systems, sterilizers (steam and gas), environmental testing and simulation systems, and other products that involve similar manufacturing techniques and engineering technologies.

ETC's unique ability to offer complete systems, designed and produced to high technical standards, sets it apart from its competition. ETC's headquarters is in Southampton, PA. For more information about ETC, visit http://www.etcusa.com/.

Forward-looking Statements

This news release contains forward-looking statements, which are based on management's expectations and are subject to uncertainties and changes in circumstances. Words and expressions reflecting something other than historical fact are intended to identify forward-looking statements, and these statements may include terminology such as "may", "will", "should", "expect", "plan", "anticipate", "believe", "estimate", "future", "predict", "potential", "intend", or "continue", and similar expressions. We base our forward-looking statements on our current expectations and projections about future events or future financial performance.

Our forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about ETC and its subsidiaries that may cause actual results to be materially different from any future results implied by these forward-looking statements. We caution you not to place undue reliance on these forward-looking statements.

Copyright 2026 GlobeNewswire, Inc.

*Predictive Interim analysis indicates low probability of study meeting its primary efficacy endpoint if continued

*Comprehensive analysis and evaluation of available open-label extension data will follow

*No safety concerns were identified in the interim analysis

PARSIPPANY, N.J., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that it will discontinue the Phase 2 TOPAS-MSA study (NCT06568237) evaluating emrusolmin (TEV-'286) in adults with multiple system atrophy (MSA).

The decision follows a recommendation from the independent data monitoring committee (IDMC), based on a prespecified interim futility analysis. The analysis met the predefined futility criterion, indicating a low probability of the study meeting its primary efficacy endpoint if continued. This was an interim predictive assessment and not the study's final efficacy analysis. No safety concerns were identified in the interim analysis.

Emrusolmin is being developed in partnership with MODAG GmbH. A comprehensive analysis of the TOPAS-MSA data and available data from the open-label extension study of emrusolmin in MSA (NCT07197866) will follow. The decision announced today concerns TOPAS-MSA and does not represent a final decision on the broader emrusolmin program.

"While we are disappointed by the outcome of this interim analysis for the Phase 2 study, we remain deeply committed to learning everything we can from these data," said Eric Hughes, M.D., Ph.D., Executive Vice President, Global R&D and Chief Medical Officer at Teva. "We are deeply grateful to the patients, families, investigators, and study teams who contributed their time and commitment to this research. Our hope is that the science and learnings can deepen our understanding of MSA and help us determine a path forward for emrusolmin."

Teva will work with the TOPAS-MSA study investigators to ensure the study protocols are followed while the Phase 2 study is discontinued. Teva plans to share the TOPAS-MSA findings with the scientific community following completion of its comprehensive analysis.

Teva to Host Q3 Earnings Call on November 3, 2026

Teva will host its third-quarter 2026 earnings conference call on November 3, 2026 at 8:00 a.m. ET. Register here. A live webcast of the call will be available on Teva's website at: https://ir.tevapharm.com/Events-and-Presentations.

About the TOPAS-MSA Program

TOPAS-MSA (NCT06568237; TV56286-NDG-20039) is a randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy and safety of emrusolmin in adults with multiple system atrophy (MSA). The study was designed to enroll approximately 350 participants to receive emrusolmin 300 mg or placebo for approximately 48 weeks, followed by a four-week follow-up period. The primary endpoint is change from baseline to Week 48 in the modified Unified Multiple System Atrophy Rating Scale Part I score.

The separate Phase 2 open-label extension (OLE) study (NCT07197866; TV56286-NDG-20041) is designed to evaluate the long-term safety and tolerability of emrusolmin in eligible participants who completed the 48-week treatment period of TOPAS-MSA.

About emrusolmin

emrusolmin, also known as TEV-'286, is an investigational, orally administered small molecule designed to target alpha-synuclein aggregation, one of the core pathogenic mechanisms believed to be involved in MSA. Emrusolmin is being developed in partnership with MODAG GmbH. The U.S. Food and Drug Administration granted Orphan Drug designation to emrusolmin for MSA in 2022 and Fast Track designation in September 2025.

About Multiple System Atrophy (MSA)

MSA is a rare neurodegenerative disorder classified clinically as "atypical parkinsonism" and belongs to the group of synucleinopathies. MSA is characterized histopathologically by abnormal deposits of the α-synuclein protein, mainly in oligodendroglial cells (glial cytoplasmic inclusions) and also in certain nerve cells. Typically, there is a dysfunction of the autonomic nervous system, i.e., disturbances of bladder function, erectile function, intestinal mobility, or the regulation of blood pressure in combination with a movement disorder.

The movement disorder often presents with either Parkinson-like symptoms or a disturbance of cerebellar function, such as ataxia, gait and speech problems. In the US, EU, and Japan, MSA affects about 40,000 people (prevalence of 4 per 100,000), with about 6,000 new cases diagnosed each year (incidence of 0.6 per 100,000). Post-diagnosis life expectancy is about 6-10 years. Due to the relatively small number of affected patients and lack of effective therapy, MSA qualifies for orphan status, allowing a shorter development path. This unmet medical need for MSA disease modification is the driver to develop new therapies that could potentially impact the lives of patients.

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva's commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients' needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause Teva's future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements.

All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. In some cases, you can identify these forward-looking statements by the use of words such as "should," "expect," "anticipate," "developing," "target," "may," "expand," "intend," "plan," "believe" and other words and terms of similar meaning and expression in connection with any discussion of future performance.

Important factors that could cause or contribute to such differences include risks and uncertainties relating to: our ability to develop emrusolmin (TEV-'286) for the treatment of MSA in adults; our ability to successfully compete in the marketplace including our ability to develop and commercialize additional pharmaceutical products; our ability to successfully execute our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and profitably commercialize the innovative medicines and biosimilar portfolio, whether organically or through business development, and to execute on our organizational transformation and to achieve expected cost savings; our significant indebtedness, which may limit our ability to incur additional indebtedness, engage in additional transactions or make new investments; and other factors discussed in this press release, in our Quarterly Report on Form 10-Q for the second quarter of 2026 and in our Annual Report on Form 10-K for the year ended December 31, 2025, including in the sections captioned "Risk Factors," "Other Information" and "Cautionary Note Regarding Forward Looking Statements."

Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.

Copyright 2026 GlobeNewswire, Inc.

YYForce presents its reported book equity alongside its market capitalization to give investors additional context for its growth plans

SINGAPORE, Nov. 02, 2026 (GLOBE NEWSWIRE) -- YYForce Inc. (Nasdaq: YFOR) ("YYForce" or the "Company"), a technology-enabled provider of workforce solutions and integrated facility management services, today highlighted its reported net assets of approximately US$21.9 million, compared with an estimated market capitalization of approximately US$2.1 million as of October 30, 2026, and outlined its commercial robotics and AI priorities.

YYForce is providing this information to help investors evaluate its reported asset base alongside its operating results, liquidity and strategy across workforce platforms, integrated facility management and service robotics.

Reported financial position and valuation comparison

As reported in the Company's Form 6-K filed on September 25, 2026, YYForce's consolidated balance sheet as of June 30, 2026, showed the following amounts.

Book equity does not represent unrestricted cash, tangible net assets, liquidation proceeds or an estimate of intrinsic value. Asset carrying values are subject to accounting estimates and impairment assessments. Investors should consider the full financial statements, including liabilities, operating results, cash flows and subsequent disclosures.

Management commentary

"We believe the difference between our reported book equity and public market capitalization warrants investors' attention," said Mike Fu, Chief Executive Officer of YYForce. "Our responsibility is to provide clear financial information and execute our commercial strategy. We remain focused on customer delivery, disciplined capital allocation and developing our workforce, facility management and service robotics businesses."

"We will evaluate each investment against customer demand, available liquidity, capital requirements and expected returns," Mr. Fu added.

Strategic growth priorities

Commercial robotics expansion. Pursuing service robotics deployments and integration with hospitality and enterprise workflows, with attention to customer requirements, deployment costs and ongoing support.

AI-enabled facility and workforce platforms. Developing digital platform capabilities and pursuing enterprise adoption to support workforce coordination, shift delivery and facility operations.

Capital discipline and market transparency. Evaluating commercial deployments against customer demand, capital requirements and expected returns, while providing shareholders with clear updates on material developments.

YYForce will continue to assess its operating performance, financing requirements and capital allocation priorities as its business develops. Future commercial progress remains subject to operational execution, customer adoption and broader market conditions.

About YYForce Inc.

YYForce Inc. (Nasdaq: YFOR) is a technology-enabled provider of workforce solutions and integrated facility management services. The Company is developing AI-enabled workforce platforms and robotics capabilities to support frontline operations, improve productivity and address evolving customer needs.

For more information, visit www.yyforce.ai.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on the Company's current expectations, assumptions and information available to it as of the date of this release. Forward-looking statements can be identified by words such as "may," "will," "should," "expects," "anticipates," "plans," "intends," "believes," "estimates," "potential" or similar expressions, or the negative of these terms.

Forward-looking statements in this release include, but are not limited to, expectations regarding the Company's strategy, commercial deployments, platform development, operational efficiency, capital allocation and future business performance. Historical financial figures are not forward-looking statements. Reported book equity is not an indication of the price at which the Company's shares may trade or of amounts that would be realized on any sale or liquidation.

Forward-looking statements involve inherent risks and uncertainties, and the forward-looking events discussed in this press release may not occur, actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about the Company and a number of factors. For a more detailed discussion of risk factors, please refer to the Company's filings with the U.S. Securities and Exchange Commission, including the "Risk Factors" section of the Company's most recent annual report on Form 20-F, as amended. YYForce undertakes no obligation to update these statements except as required by applicable law.

Copyright 2026 GlobeNewswire, Inc.

WATERLOO, Ontario and ATLANTA, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that its Descartes MacroPoint Advanced Ocean Visibility solution is now integrated with SAP Business Netwoark Freight Collaboration and SAP Business Network Global Track and Trace through a standardized connection to the Descartes Global Logistics Network (Descartes GLN).

The combined solution provides shippers with access to expanded multimodal visibility capabilities within their SAP transportation environments.

"As supply chains become increasingly global, multimodal and disruption-prone, organizations require more timely and consistent visibility across transportation modes to improve planning and execution," said Dan Cicerchi, EVP, Corporate & Operations Development at Descartes. "By bringing our ocean visibility data directly into SAP's leading transportation platforms from the Descartes GLN, shippers can gain a more complete view of global shipments, improve operational responsiveness and strengthen supply chain resilience."

Ocean visibility data from the Descartes GLN flows into SAP Business Network Freight Collaboration and SAP Business Network Global Track and Trace, providing near real-time container-level tracking of departures, arrivals, loading events, gate movements and other critical milestones within customers' existing SAP workflows.

This creates a consistent visibility experience across both ocean and road transportation movements. By combining standardized APIs, harmonized data models, and continuously updated logistics event data, the combined solution simplifies deployment, delivers multimodal visibility at scale, and provides a trusted foundation for analytics, automation, and AI-driven supply chain innovation. The comprehensive testing program confirmed production-ready performance, reliable event exchange, accurate milestone tracking and robust support for complex shipment scenarios across the full shipment lifecycle.

The new end-to-end connection builds on the existing Descartes GLN integration with SAP Business Network Freight Collaboration, which supports processes such as carrier booking. Descartes MacroPoint Advanced Ocean Visibility is available on the SAP? Store.

SAP Store, found at store.sap.com, delivers a simplified and connected digital customer experience for finding, trying, buying and renewing more than 2,300 solutions from SAP and its partners. There, customers can find the SAP solutions and SAP-validated solutions they need to grow their business. And for each purchase made through SAP Store, SAP will plant a tree.

Descartes is a partner in the SAP PartnerEdge program. The SAP PartnerEdge program provides the enablement tools, benefits and support to facilitate building high-quality, disruptive applications focused on specific business needs ? quickly and cost-effectively.

About Descartes

Descartes powers more responsive, efficient, secure and sustainable international and domestic supply chains by uniting logistics-intensive businesses on its Global Logistics Network (GLN). Shippers, carriers, and logistics service providers connect and collaborate on the GLN leveraging technology, data and AI to manage last mile deliveries, domestic and international shipments, transportation rating and payment, global trade research, customs compliance and a variety of regulatory processes. Learn more about Descartes at www.descartes.com and connect with us on LinkedIn and X.

SAP and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP SE in Germany and other countries. Please see https://www.sap.com/copyright for additional trademark information and notices. All other product and service names mentioned are the trademarks of their respective companies.

Descartes Media Contact

Andra Schaz

aschaz@descartes.com

Cautionary Statement Regarding Forward-Looking Statements

This release contains forward-looking information within the meaning of applicable securities laws ("forward-looking statements") that relate to Descartes' solution offerings and potential benefits derived therefrom; and other matters. Such forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, performance or achievements to differ materially from the anticipated results, performance or achievements or developments expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the factors and assumptions discussed in the section entitled, "Certain Factors That May Affect Future Results" in documents filed with the Securities and Exchange Commission, the Ontario Securities Commission and other securities regulatory authorities across Canada including Descartes' most recently filed annual and interim management's discussion and analysis which are available under Descartes' profile through the EDGAR website at http://www.sec.gov or through the SEDAR+ website at http://www.sedarplus.com/.

If any such risks actually occur, they could, among other consequences, materially adversely affect our business, financial condition or results of operations. In that case, the trading price of our common shares could decline, perhaps materially. Readers are cautioned not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Forward-looking statements are provided for the purposes of providing information about management's current expectations and plans relating to the future. Readers are cautioned that such information may not be appropriate for other purposes. Except as required by applicable law, we do not undertake or accept any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Copyright 2026 GlobeNewswire, Inc.

HONG KONG, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Hot on the heels of its spectacular annual event, the "Hong Kong Wine & Dine Festival", the Hong Kong Tourism Board (HKTB) today launched "Hong Kong Gourmet Month".

Throughout November, HKTB will join hands with more than 400 restaurants, bars and food and beverage (F&B) outlets across the city to present limited-time menus, dining offers and unique experiences. The campaign invites locals and visitors to explore different districts in search of great food and "Taste the World's Best" anytime, anywhere, every day.

The campaign features five themed dining experiences, ranging from star-rated dining, neighbourhood delicacies and distinctive drinks to authentic local late-night bites after 9pm, easily unlocking the many flavours found "Only in Hong Kong". In addition, participants in the "Hong Kong Wine & Dine Festival" can enjoy more than 250 additional exclusive privileges across the city with the "Gourmet Month Privilege Card" distributed at the venue.

Dr Peter Lam, Chairman of HKTB, said, "The 'Hong Kong Wine & Dine Festival' has drawn to a successful close, attracting visitors from around the world as well as locals, and fully showcasing Hong Kong's appeal as an international culinary capital. The 'Hong Kong Gourmet Month' now takes the benefits of the Festival further, extending them across the city. Its five themes bring together star-rated restaurants, renowned neighbourhood eateries, distinctive bars and late-night hotspots, enabling visitors and locals to enjoy Hong Kong's dining scene from day to night, every day in November. We hope the campaign will give locals and visitors alike even more reasons to explore our neighbourhoods and spend locally, creating more business opportunities for the F&B and tourism-related sectors, and fully unleashing the synergies of the mega-event economy."

Enjoy More than 250 Exclusive Privileges Across the City with the "Gourmet Month Privilege Card"

With the "Gourmet Month Privilege Card" distributed at the "Hong Kong Wine & Dine Festival", locals and visitors can enjoy more than 250 exclusive privileges at designated restaurants, bars and participating F&B merchants across the city, including offers on selected menus, dining discounts, welcome drinks, buy-one-get-one-free deals and event redemptions.

Five Themed Dining Experiences at "Hong Kong Gourmet Month" Let Locals and Visitors Explore Flavours from Lunch to Late Night

"Hong Kong Gourmet Month" features five themed dining experiences, including the "Hong Kong Wine-Pairing Award-Winning Restaurants Gala", crafted by award-winning chefs and top sommeliers; "Taste More Hong Kong", offering renowned Michelin dishes at up to 30% off; as well as the "Hong Kong Late-Night Dining Guide", "Cocktail Fest Month" and "Sip and Savour in LKF", which invite locals and visitors to explore Hong Kong's dining scene as it comes alive after dark.

Theme 1: Hong Kong Wine-Pairing Award-Winning Restaurants Gala

Star chefs and sommeliers join forces to create 15 wine-pairing menus available only during Gourmet Month.

The "Hong Kong Wine-Pairing Award-Winning Restaurants Gala: When Top Sommeliers Meet Legendary Chefs" brings together around 15 of Hong Kong's top restaurants, including Michelin three-star Tang Court; Michelin two-star Arbor; and Michelin one-star Tosca di Angelo and Andō. Drawing on the ingredients, cooking methods and flavours of each dish, as well as the characteristics of each wine, their renowned chefs and sommeliers have specially curated 15 wine-pairing menus available exclusively during "Hong Kong Gourmet Month".

At Tosca di Angelo, for example, dishes featuring ingredients such as Mediterranean tuna, Hokkaido scallops, Mediterranean sea bream and Cherry Valley duck are paired with selected wines from Abruzzo, Marche and Sicily, allowing diners to savour the terroirs and flavours of different Italian wine regions in a single meal.

Theme 2: Taste More Hong Kong (Michelin dishes at up to 30% off)

From Michelin three-star restaurants to harbour-view venues, more than 200 restaurants are offering limited-time lunch and dinner menus, with up to 30% off selected menus.

The line-up includes Michelin three-star Forum Restaurant; two-star Ying Jee Club and Bo Innovation; and one-star Hansik Goo, Man Wah, Shang Palace, Epure, and Racines. Dining options span traditional Cantonese cuisine, innovative Chinese dishes, international flavours, local neighbourhood specialities and harbour-view dining experiences.

AFTER 9 : The Later It Gets, the Better It Tastes

Theme 3: Hong Kong Late-Night Dining Guide

More than 100 restaurants and bars lead the way to the diverse flavours of Hong Kong, the city that never sleeps.

The "Hong Kong Late-Night Dining Guide" brings together nearly 80 F&B brands and more than 100 outlets across districts including Central and Sheung Wan, Wan Chai, Causeway Bay, Tsim Sha Tsui, Mongkok, Sham Shui Po and Kowloon City, offering exclusive deals after 9pm. Dining options range from dai pai dong (open-air food stalls), hotpot restaurants, izakayas, burger joints and dessert shops to hotel restaurants, harbour-view bars and fine dining. Some participating restaurants in tourist hotspots will even stay open until midnight or into the early hours of the morning, allowing locals and visitors to easily experience Hong Kong's late-night dining culture, which only gets better as the night goes on.

Theme 4: Cocktail Fest Month

"Cocktail Fest Month" handpicked 30 distinctive bars across the city and recommends six themed bar routes, covering hidden speakeasies, local Hong Kong flavours, classic bars in Central, trendy rising mixology stars, luxury hotel and renowned bars, and tipsy pairings of food and drinks. Locals and visitors are invited to hop across Hong Kong's districts to suit their tastes and explore the city's diverse and vibrant bar culture one glass at a time. During the event, participants simply pay HK$399 to choose one themed route and three participating bars, then redeem a signature drink at each bar as they embark on a themed bar-hopping journey.

Highlights include Tell Camellia in Central, renowned for its tea-infused cocktails. Its signature cocktail "Iron Tea" draws inspiration from Hong Kong's long-standing tea culture, bringing local flavours into the glass. Meanwhile, Bar Mind, co-founded by award-winning local mixologists, presents the "Sweet Potatoni", a tribute to the charcoal-roasted chestnuts and roasted sweet potatoes sold on Hong Kong's streets. Weaving together smoky tea notes and caramel sweetness for a rich local flavour, it underscores the creativity of Hong Kong's mixology scene.

Theme 5: Sip and Savour in LKF

More than 20 restaurants and bars in Lan Kwai Fong will present "Sip and Savour in LKF", a limited-edition night-time experience. Alongside special Gourmet Month food and drinks offers, there will be mixology workshops, retro-themed nights and DJ performances, offering more options for after-dinner gatherings and nights out while showcasing Lan Kwai Fong's lively and diverse nightlife.

Copyright 2026 GlobeNewswire, Inc.

SHANGHAI, Nov. 02, 2026 (GLOBE NEWSWIRE) -- The "New Design Language Launch" was held at the Chery Global Technology Innovation Center in Shanghai as part of the 2026 EXEED International User Summit. Under the theme "Future Luxury," the event unveiled EXEED's new family design language.

Brand Design Stylist Christo Pavlidis and Chief Designer Juan Manuel Diaz presented five models: the ES GT, EX9, EX8, EX7 and MPV Concept. Together, these models offer distinct interpretations of Future Luxury, responding to users' evolving expectations for luxury, performance and cutting-edge technology.

At the heart of Future Luxury is Perpetua, a design philosophy inspired by how Atlantic waves shift with light, tide and time. It takes shape in two expressions. Liquid water captures speed and tension in sport-oriented models, while the clean-cut surfaces and sculptural volumes of solid polar ice lay the foundation for future luxury models. Sportiness and luxury are not separate design languages but two expressions of the same aesthetic, enabling the design language to extend across vehicle categories.

The EX9 is the first model to fully embody this design language in the luxury segment. Its long wheelbase, short front overhang and upright body create a confident flagship SUV stance. Flush door handles and a continuous shoulder line form a sculptural silhouette, highlighting proportions, materials and light with minimal ornamentation. The EX8 emphasizes horizontal lines and offers generous space for premium SUV buyers traveling with family or in groups, while the EX7 carries forward the EX9's design cues in a sportier form. The MPV Concept explores forms beyond traditional sedans and SUVs, demonstrating the versatility of Future Luxury across vehicle categories.

The ES GT expresses a more dynamic side of Future Luxury. As EXEED's first crossover wagon, its low, elongated body conveys forward motion even at a standstill. Inside, a symmetrical wraparound cockpit features a Sky Screen and floating center display, while integrated sport seats offer active lateral support. Its sporty design carries through to the driving experience, bringing EXEED's racing DNA into the cabin.

After the event, the design team held a workshop with global user representatives. Their feedback will help EXEED better understand user needs. Building on SIVP, Texxeract and its racing DNA, EXEED is shaping a new vision for mobility in global markets through design, performance and cutting-edge technology.

Copyright 2026 GlobeNewswire, Inc.

SHANGHAI, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Sigenergy, a global pioneer in next-generation energy storage solutions, has just been designated as a Tier 1 Energy Storage Manufacturer by BloombergNEF (BNEF) for the fourth quarter of 2026. This prestigious benchmark highlights Sigenergy's exceptional financial stability, robust bankability, and field-proven product reliability across major global markets.

BloombergNEF's Tier 1 rating is widely recognized as one of the most rigorous independent evaluation frameworks in the renewable energy sector. Designed to provide transparent market intelligence, the Tier 1 designation assesses manufacturers based on stringent criteria including financial health, demonstrated project delivery track records, and strict quality standards.

For global investors, Engineering, Procurement, and Construction (EPC) contractors, project developers, and asset owners, Sigenergy's Tier 1 status offers strong assurance of long-term operational stability and technical performance, facilitating smoother project financing and risk mitigation across the energy value chain.

The Tier 1 status validates Sigenergy's rapid worldwide growth, fueled by continuous R&D investment and its visionary "AI in All" strategy. By integrating artificial intelligence into its flexible, modular product architecture, Sigenergy delivers highly reliable, innovative energy storage solutions tailored for diverse applications, ranging from Commercial & Industrial (C&I) projects to complex, utility-scale power plants.

This milestone reinforces Sigenergy's commitment to empowering a broader spectrum of global customers, asset owners, and partners with scalable efficiency, robust safety, and long-term project value.

About Sigenergy

Founded in 2022 and headquartered in Shanghai, Sigenergy (6656.HK) is a technology-driven company focused on innovation in the new energy sector. Leveraging advanced digital intelligence and a highly skilled talent base, the company has expanded across photovoltaic(PV)generation, smart energy storage and high-efficiency electric vehicle (EV) charging solutions.

Guided by its "AI in All" strategy, Sigenergy integrates artificial intelligence across its product ecosystem to deliver safer, smarter and more efficient energy solutions for households and businesses worldwide.

Copyright 2026 GlobeNewswire, Inc.

ZURICH , Nov. 02, 2026 (GLOBE NEWSWIRE) -- As governments compete to attract international capital, entrepreneurs and talent, and families increasingly seek to diversify their residence and citizenship options, policymakers, academics, investors and industry experts will gather in Zurich next month for the landmark 20th Global Citizenship Conference.

Hosted by Henley & Partners from 23-25 November 2026 at The Dolder Grand, the anniversary edition will bring together over 400 government representatives, economists, international investors, family office principals, wealth management professionals and global mobility specialists to examine the forces reshaping the future of global citizenship.

Over the past two decades, the conference has evolved alongside investment migration, which has grown from a relatively niche field into an increasingly important component of international wealth planning and national economic development strategies.

Two decades of transformation in global citizenship

The milestone comes as heightened geopolitical uncertainty, demographic pressures and changing migration policies reshape the relationship between individuals and states.

Dr. Christian H. K?lin, Chairman of Henley & Partners, says: "Twenty years ago, we founded this conference on a simple conviction: where you are born should not define the limits of your future. For families, additional citizenships and residency rights can open opportunities for generations. For countries, well-designed pathways can attract the talent and investment that underpin lasting prosperity."

Since the conference's inception, governments have increasingly integrated residence and citizenship frameworks into broader strategies for attracting investment, encouraging entrepreneurship and strengthening economic competitiveness.

Dr. K?lin adds: "Two powerful forces are converging: families want greater freedom to choose where they live, work and invest, while governments need to compete for the talent and capital that will shape their future. Citizenship is more than an identity. It is a portfolio of legal rights and opportunities that can shape lives for generations and forge lasting ties between individuals and nations."

Growing demand from established democracies

The anniversary coincides with increased global demand for international residence and citizenship options, including rising interest from citizens of some of the world's wealthiest and most established democracies.

Henley & Partners has worked with clients from more than 100 nationalities across 50 different residence and citizenship programme options over the past 10 months, with 36% of applicants already living outside their country of origin. US nationals account for nearly a quarter of the firm's clients, while the UK ranks 6th, Germany 9th and France has climbed from 36th to 14th in terms of client applications. Australia and Canada are also among the top 15 client nationalities, while India leads enquiries.

Dr. Juerg Steffen, CEO of Henley & Partners, says this shift reflects a more strategic approach to managing long-term uncertainty, rather than an explicit intention to emigrate or a loss of confidence in home countries. "What is particularly striking is that many of these families already enjoy considerable global mobility. However, intensified geopolitical, fiscal and regulatory uncertainty is encouraging them to build sovereign portfolios - complementary residence and citizenship rights, investments and personal ties across different jurisdictions."

The next era of global mobility and sovereign competitiveness

Against this backdrop, the conference programme will tackle one of the most pressing policy dilemmas facing Europe and other developed economies: how governments can respond to growing public concerns about immigration and demands for tighter controls while continuing to attract the investors, entrepreneurs and skilled professionals needed to support economic growth.

The programme will also explore the changing geography of global wealth and mobility, the success of small nations in competing for international capital and talent, and the emergence of new centres for investment, entrepreneurship and international residence. Other key topics include the United States' position as both a major destination for international investors and a growing source of outbound demand, the evolving global tax landscape, and the integration of mobility planning into broader family wealth, investment and succession strategies.

Beyond investment migration, the conference will examine displacement and statelessness, the growing significance of digital identity and border technology, and how demographic change, technological advances and geopolitical fragmentation are reshaping global movement.

Celebrating global citizenship in action

A highlight of the annual conference is the Global Citizen Award Gala Dinner on 24 November, honouring an exceptional individual whose courage and commitment have helped address some of the most pressing issues of our time - challenges that transcend national borders and demand a global response.

The award is presented in partnership with the Swiss-based non-profit Andan Foundation, established to support refugees and other forcibly displaced people through initiatives promoting self-reliance, inclusion and economic opportunity.

Copyright 2026 GlobeNewswire, Inc.

SINGAPORE, Nov. 01, 2026 (GLOBE NEWSWIRE) -- Hotel101 Global Holdings Corp. (NASDAQ: HBNB) ("Hotel101 Global," "Hotel101," "HBNB" or the "Company") today announced that the monthly performance of its 680-room Hotel101-Madrid has significantly exceeded the Company's expectations.

In October 2026, Hotel101-Madrid achieved a record high of EUR2.931 million (equivalent to approx. US$3.28 million) in recurring revenues from stays during the month, with average occupancy of 97.41%.

This record performance reflects the continued momentum and exceptionally strong demand for Hotel101-Madrid, the first Hotel101-branded property to operate outside the Philippines, which opened in March 2026. The Company believes the results provide clear evidence of robust underlying demand in a major European market and demonstrates Hotel101-Madrid's ability to generate recurring revenues at scale.

Management believes this property's October performance is indicative of Hotel101's potential to contribute meaningful annual recurring hotel revenues and further validates the Company's asset-light, prop-tech hospitality model and its emphasis on long-term, recurring revenue generation across the Hotel101 global portfolio.

Key Operating Highlights - Hotel101-Madrid (October 2026)

Monthly recurring revenue from October 2026 stays: ?2,929,7781 (a property record for any single month)

Average occupancy: 97.41%

Property size: 680 standardized HappyRooms

The Company believes these results reflect the effectiveness of Hotel101's globally standardized "HappyRoom" concept and tech-enabled operating platform in attracting demand. The high occupancy also benefits unit owners, who collectively receive 30% of monthly gross room revenues net of applicable taxes and statutory charges, distributed equally across all units and paid by the 16th day of the following month.

Hotel101-Madrid serves as the global prototype of the Hotel101 concept and primary operating springboard for the Company's international expansion. Located in the dynamic Valdebebas district, just minutes from Adolfo Su?rez Madrid-Barajas International Airport and IFEMA, one of Europe's largest convention and exhibition centers, the 680-room property sits adjacent to the Real Madrid Sports City and the Formula 1 Spanish Grand Prix circuit, placing it at the heart of Madrid's premier sports and events zone.

Hotel101-Madrid has demonstrated strong international guest appeal, earning a 9.1 "Exceptional" rating based on more than 9,700 reviews across major online travel agencies as of October 31, 2026. Since opening in March 2026 through October 31, 2026, arrivals have been led by guests from Spain (39%), the United States (7%), Portugal (4%), China (3%), and Mexico (3%), reflecting strong appeal across multiple continents. Europe has accounted for nearly two-thirds of all arrivals (63.3%), followed by Latin America (16.1%), North America (8.5%), and Asia (6.2%). With guests from over 100 nationalities, including a growing number of Filipinos (0.55% of the more than 95,500 arrivals since opening in March 2026), Hotel101-Madrid has rapidly established itself as an international destination.

Management expects Hotel101-Madrid's performance to support the replication of the Hotel101 business model through joint ventures and, in the future, license agreements, advancing Hotel101 Global's long-term vision of developing one million standardized rooms across 100 countries and its aspiration to become one of the top hotel brands globally.

About Hotel101 Global

Listed on Nasdaq (Ticker: HBNB) with a market capitalization of approx. US$1.11 billion as of October 30, 2026, Hotel101 is an asset-light, prop-tech hospitality platform pioneering a globally standardized "condotel" business model. Hotel101 aims to disrupt the global hotel and hospitality sector through its unique tech-enabled business model that positions it to generate revenues twice: first from the advance sale of individual hotel units during the construction phase; and second, from long-term recurring revenue derived from day-to-day hotel operations. The expansion of Hotel101 toward its long-term goal to operate in 100 countries globally is expected to be driven mainly by joint ventures and, in the future, license agreements with local developers in various countries worldwide.

Hotel101 is advancing its global expansion plans toward its medium-term goal to be in 25 countries and its long-term goal of operating one million Hotel101 rooms in 100 countries globally.

1 The monthly recurring revenue figure in this release is a preliminary, unaudited management estimate based on information available as of the date of this release, relates only to stays at Hotel101-Madrid in October 2026 and are subject to change.

Hotel101 Global Holdings Corp.

Forward-Looking Statements

This document includes certain "forward-looking statements" within the meaning of securities laws of certain jurisdictions, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this document, including statements regarding the future financial position, business strategy, plans and objectives of management for future operations of Hotel101 Global Holdings Corp.

("HBNB") and its subsidiaries (the "HBNB Group"), are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "set," "expect," "aim," "goal," "predict," "potential" or the negative of these terms or other similar expressions. Forward-looking statements include, without limitation, HBNB's expectations concerning anticipated recurring hotel revenues, the replication of its business model, expected number of rooms and expansion goals, the outlook for the HBNB Group's business, productivity, plans and goals for future operational improvements and capital investments, operational performance, future market conditions or economic performance and developments in the capital and credit markets and expected future financial performance, as well as any information concerning possible or assumed future results of operations of the HBNB Group.

These forward-looking statements are based on the beliefs and assumptions of the management of HBNB. Although HBNB believes that such plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, HBNB cannot assure you that such plans, intentions or expectations will be achieved or realized. Forward-looking statements involve a number of risks, uncertainties and assumptions and actual results or events may differ materially from those projected or implied in those statements.

Results for any single month are not necessarily indicative of results for any future period. Factors that may cause actual results to differ materially from current expectations include, but are not limited to, the HBNB Group's ability to execute on its business model, potential business expansion opportunities in foreign countries and growth strategies, manage future growth, retain and expand customers' use of its hotel services and attract new customers, and source and maintain talent; risks relating to joint venture partners, including owners of pre-sold condotel units in Hotel101 hospitality projects, who may have interests different from and may take actions that adversely affect the HBNB Group; risks relating to project cost and completion; risks relating to the HBNB Group's sources of cash and cash resources; risks relating to offering deferred payment schemes, including the risk of customer default; the HBNB Group's ability to effectively compete in the highly competitive hospitality industry; seasonality and fluctuations in hotel demand; any declines or disruptions in the travel and hospitality industries or economic downturn; applicable laws and regulations to real estate development and marketing activities and hotel operation and management activities in the jurisdictions where the HBNB Group has operations or intends to expand into; and other risks and uncertainties discussed in HBNB's annual report for the year ended December 31, 2025 on Form 20-F and under the heading "Risk Factors" in HBNB's registration statement on Form F-4 (File No.: 333-287130) and other documents to be filed by HBNB from time to time with the U.S. Securities and Exchange Commission.

The foregoing list of factors is not exhaustive. Should one or more of these risks or uncertainties materialize, or should any of HBNB's assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. There may be additional risks that are not presently known to HBNB or that HBNB currently believes are immaterial that could also cause actual results to differ from those contained in the forward-looking statements.

HBNB cautions you against placing undue reliance on forward-looking statements, which reflect current beliefs and are based on information currently available as of the date hereof. Forward-looking statements set forth herein speak only as of the date of this document.

HBNB does not undertake any obligation to revise forward-looking statements to reflect future events, changes in circumstances, or changes in beliefs. In the event that any forward-looking statement is updated, no inference should be made that HBNB will make additional updates with respect to that statement, related matters or any other forward-looking statements.

Copyright 2026 GlobeNewswire, Inc.

Perth, Australia - November 2, 2026 - Atos, a global leader of AI-powered digital transformation, today announces the appointment of Judith Stewart as Head of Healthcare & Life Sciences for Asia Pacific, reinforcing the company's commitment to accelerating growth and innovation across the sector and helping organizations harness the potential of artificial intelligence, sovereign technologies and cybersecurity.

Judith brings more than 18 years of international healthcare leadership experience, with a strong track record delivering healthcare reforms and transformations for public and private sector organizations across Australia and the UK. Prior to joining Atos, she held Executive roles for several years within WA Health, most recently as Executive Director for Child and Adolescent Community Health Services in Perth, Western Australia.  

In her new role, Judith will lead Atos' Healthcare & Life Sciences business across Asia Pacific, with a focus on accelerating growth, strengthening customer relationships, fostering innovation and supporting clients as they navigate an increasingly complex technology landscape.

Daniele Principato, EVP and Head of International Markets at Atos, said:

"Judith brings extensive healthcare leadership experience and a deep understanding of the challenges facing the sector. Her appointment strengthens our Healthcare & Life Sciences capabilities in Asia Pacific and our ability to help clients accelerate transformation while addressing critical priorities around AI, cybersecurity and digital sovereignty."

Judith Stewart, Head of Healthcare & Life Sciences, Asia Pacific at Atos, said:

"I am delighted to join Atos and look forward to working with our talented teams, customers and partners across Asia Pacific. Healthcare and Life Sciences organizations are navigating significant change, and technology and AI have an important role to play in helping them transform and innovate. I look forward to helping our clients unlock that potential and deliver meaningful outcomes for the communities they serve."

The appointment reflects Atos' continued investment in Asia Pacific and its commitment to supporting Healthcare & Life Sciences organizations as they harness advanced technologies to transform healthcare delivery, strengthen resilience and drive sustainable innovation.

About Atos

Atos is the Atos Group brand dedicated to AI-powered, secure, end-to-end digital services. Atos designs, develops, and operates critical digital environments that drive performance, resilience and sovereignty, helping public and private organizations worldwide retain control over their data and infrastructures, while meeting regulatory requirements.

With more than 51,000 employees serving over 4,500 clients across 54 countries, Atos helps modernize core IT systems, accelerate cloud and data transformation, strengthen cybersecurity, and deliver secure digital workplace environments to support its clients, its employees and society. Atos also provides consulting and advisory services through its Atos Amplify brand.

A trusted partner in operating complex and mission-critical environments, Atos supports organizations across highly regulated and sovereign contexts.

About Atos Group

Atos Group is a global leader in digital transformation with c. 53,000 employees and annual revenue of c. ?7.2 billion, operating in 54 countries under two brands - Atos for services and Eviden for products and systems.

European number one in cybersecurity and a leader in cloud, Atos Group is committed to a secure and decarbonized future and provides tailored AI-powered, end-to-end solutions for all industries. Atos Group is listed on Euronext Paris.

Copyright 2026 GlobeNewswire, Inc.